American Journal of Epidemiology Advance Access originally published online on May 15, 2007
American Journal of Epidemiology 2007 166(3):348-354; doi:10.1093/aje/kwm070
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ORIGINAL CONTRIBUTIONS |
Adherence to Lipid-lowering Therapy and the Use of Preventive Health Services: An Investigation of the Healthy User Effect
1 Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital/Harvard Medical School, Boston, MA
2 Therapeutics Initiative, University of British Columbia, Vancouver, BC, Canada
Correspondence to Dr. M. Alan Brookhart, Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital/Harvard Medical School, 1620 Tremont Street, Suite 3030, Boston, MA 02120 (e-mail: abrookhart{at}rics.bwh.harvard.edu).
Received for publication November 7, 2006. Accepted for publication January 31, 2007.
Patients who adhere to preventive therapies may be more likely to engage in a broad spectrum of behaviors consistent with a healthy lifestyle. Because many of these behaviors cannot be measured easily, observational studies of outcomes associated with the long-term use of preventive therapies are subject to the so-called "healthy user bias." To better understand this effect, the authors examined the association between adherence to statin therapy and the use of preventive health services in a Pennsylvania cohort of 20,783 new users of statins between 1996 and 2004. After adjustment for age, gender, and various comorbid conditions, patients who filled two or more prescriptions for a statin during a 1-year ascertainment period were more likely than patients who filled only one prescription to receive prostate-specific antigen tests (hazard ratio (HR) = 1.57, 95% confidence interval (CI): 1.17, 2.19), fecal occult blood tests (HR = 1.31, 95% CI: 1.12, 1.53), screening mammograms (HR = 1.22, 95% CI: 1.09, 1.38), influenza vaccinations (HR = 1.21, 95% CI: 1.12, 1.31), and pneumococcal vaccinations (HR = 1.46, 95% CI: 1.17, 1.83) during follow-up. These results suggest that patients who adhere to chronic therapies are more likely to seek out preventive health services, such as screening tests and vaccinations. Further work is needed to identify study design and analysis methods that can be used to minimize the healthy user bias in studies of preventive therapies.
bias (epidemiology); confounding factors (epidemiology); epidemiologic methods; health behavior; pharmacoepidemiology
Abbreviations: CI, confidence interval; HR, hazard ratio; PACE, Pharmaceutical Assistance Contract for the Elderly
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  R P Young, R Hopkins, and T E Eaton Potential benefits of statins on morbidity and mortality in chronic obstructive pulmonary disease: a review of the evidence Postgrad. Med. J., August 1, 2009; 85(1006): 414 - 421. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. Snyder and A. J. Collins Association of Preventive Health Care with Atherosclerotic Heart Disease and Mortality in CKD J. Am. Soc. Nephrol., July 1, 2009; 20(7): 1614 - 1622. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Dublin, M. L Jackson, J. C Nelson, N. S Weiss, E. B Larson, and L. A Jackson Statin use and risk of community acquired pneumonia in older people: population based case-control study BMJ, June 16, 2009; 338(jun16_1): b2137 - b2137. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. M. Ho, C. L. Bryson, and J. S. Rumsfeld Medication Adherence: Its Importance in Cardiovascular Outcomes Circulation, June 16, 2009; 119(23): 3028 - 3035. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. R. Dormuth, A. R. Patrick, W. H. Shrank, J. M. Wright, R. J. Glynn, J. Sutherland, and M. A. Brookhart Statin Adherence and Risk of Accidents: A Cautionary Tale Circulation, April 21, 2009; 119(15): 2051 - 2057. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. C. Winkelmayer, S. Setoguchi, R. Levin, and D. H. Solomon Comparison of Cardiovascular Outcomes in Elderly Patients With Diabetes Who Initiated Rosiglitazone vs Pioglitazone Therapy Arch Intern Med, November 24, 2008; 168(21): 2368 - 2375. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Boudreau, E. Koehler, S. J. Rulyak, S. Haneuse, R. Harrison, and M. T. Mandelson Cardiovascular Medication Use and Risk for Colorectal Cancer Cancer Epidemiol. Biomarkers Prev., November 1, 2008; 17(11): 3076 - 3080. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kulik, M. A. Brookhart, R. Levin, M. Ruel, D. H. Solomon, and N. K. Choudhry Impact of Statin Use on Outcomes After Coronary Artery Bypass Graft Surgery Circulation, October 28, 2008; 118(18): 1785 - 1792. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Redelmeier MD MSHSR, D. Thiruchelvam MSc, and N. Daneman MD Delirium after elective surgery among elderly patients taking statins Can. Med. Assoc. J., September 23, 2008; 179(7): 645 - 652. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. T. Eurich, T. J. Marrie, J. Johnstone, and S. R. Majumdar Mortality Reduction with Influenza Vaccine in Patients with Pneumonia Outside "Flu" Season: Pleiotropic Benefits or Residual Confounding? Am. J. Respir. Crit. Care Med., September 1, 2008; 178(5): 527 - 533. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Falagas, G. C. Makris, D. K. Matthaiou, and P. I. Rafailidis Statins for infection and sepsis: a systematic review of the clinical evidence J. Antimicrob. Chemother., April 1, 2008; 61(4): 774 - 785. [Abstract] [Full Text] [PDF]
|
|